Sun Pharma, Jet Airways, Prabhat Dairy, Laurus Labs and Maruti Suzuki

New Delhi, December 05, 2018:  Nifty futures on the Singapore Exchange were trading 67.50 points, or 0.62 per cent, higher at 10,977.50, indicating a gap-upstart for the Nifty50. Here are a few stocks which may buzz the most in today’s session:

Sun Pharma: The drug maker will hold investo call at 6.30 pm today according to reports published in economictimes.indiatimes.com

Prabhat Dairy: Tata Sons has rejected a proposal by group’s mergers & acquisitions team for Tata Global Beverages Ltd to buy Prabhat Dairy for about Rs 400 crore. The board did not see it as significant enough to scale up the business in the challenging dairy sector.

State Bank of India: SBI has put up for sale three of its non-performing loan accounts to recover dues worth Rs 2,110.7 crore. An e-auction will take place on December 13 for the sale of these three accounts — Sona Alloys, MCL Global Steel and Jayaswal Neco Industries.

Laurus Labs: Hyderabad-based pharma company said it has launched a new HIV drug with the triple combination of Tenofovir Disoproxil Fumarate, Lamivudine and Dolutegravir (TLD) in South Africa.

Cadila Healthcare: Drug firm Zydus Cadila said that it has received an approval from the US health regulator to market Teriflunomide tablets, used to treat relapsing forms of multiple sclerosis (MS).

Shree Cement: Kolkata-based Shree CementNSE -0.67 % will invest around Rs 1,000 crore to set up two grinding units – one each in Jharkhand and Odisha – in the next one year with an eye on enhancing presence in east India, according a top company official.

Jet Airways: Jet Airways is rationalising its international network trimming unviable flights and adding new ones where it hopes to make money, as the cash strapped carrier makes efforts to itself turn around while simultaneously seeking a cash infusion to keep itself afloat.

Bank of Maharashtra: State-owned Bank of Maharashtra announced that A S Rajeev has joined the lender as its Managing Director & Chief Executive Officer.

Biocon: Biosimilar Pegfilgrastim co-developed by Biocon has received approval in EU.

Mahindra & Mahindra: The company reported 16 per cent increase in total sales at 45,101 units in November.The company had sold 38,570 units in the same month last year, Mahindra & Mahindra said in a statement.

Maruti Suzuki: The country’s largest car maker Maruti Suzuki India on Saturday reported marginal decline in sales at 1,53,539 units for the month of November.The company had sold 1,54,600 units in November last year, Maruti Suzuki India (MSI) said in a statement.

Tata Motors: Tata Motors Saturday reported 3.8 per cent decline in domestic sales to 50,470 units in November as compared to 52,464 in the same month last year.

Hero MotoCorp: The country’s largest two-wheeler maker Hero MotoCorpNSE 0.96 % reported a marginal increase in its sales to 6,10,252 units in November.The company had sold 6,05,270 units in November 2017, Hero MotoCorp said in a statement.

NHPC: State-owned hydro power giant NHPC Sunday said it has entered into agreement with the country’s largest lender State Bank of India for a term-loan of Rs 500 crore.

ICICI Securities: The brokerage has been selected to advise the Finance Ministry on two merger and acquisition (M&A) deals, an official said.

Bharti Airtel: The telecom major is preparing for a bigger enterprise play through its new cloud and data centre strategy with an aim to become the country’s largest data centre company by providing its infrastructure to global players like Microsoft and app makers, among others.